Evidence map›Paper›PMID 38255961›Full record

ArticleInternational journal of molecular sciences2024

Untranslated Region Sequences and the Efficacy of mRNA Vaccines against Tuberculosis.

Vasiliy Reshetnikov, Ilya Terenin, Galina Shepelkova, Vladimir Yeremeev, Semyon Kolmykov, Maxim Nagornykh, Elena Kolosova, Tatiana Sokolova, Olga Zaborova, Ivan Kukushkin and 8 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Vasiliy ReshetnikovTranslational Medicine Research Center, Sirius University of Science and Technology, 354340 Sochi, Russia.ORCID 0000-0002-2932-0804
Ilya TereninTranslational Medicine Research Center, Sirius University of Science and Technology, 354340 Sochi, Russia.ORCID 0000-0002-4459-0781
Galina ShepelkovaCentral Tuberculosis Research Institute, 107564 Moscow, Russia.ORCID 0000-0001-6854-7932
Vladimir YeremeevCentral Tuberculosis Research Institute, 107564 Moscow, Russia.ORCID 0000-0001-6608-7557
Semyon KolmykovTranslational Medicine Research Center, Sirius University of Science and Technology, 354340 Sochi, Russia.ORCID 0000-0002-9259-0495
Maxim NagornykhTranslational Medicine Research Center, Sirius University of Science and Technology, 354340 Sochi, Russia.
Elena KolosovaTranslational Medicine Research Center, Sirius University of Science and Technology, 354340 Sochi, Russia.
Tatiana SokolovaTranslational Medicine Research Center, Sirius University of Science and Technology, 354340 Sochi, Russia.ORCID 0000-0003-3393-3096
Olga ZaborovaTranslational Medicine Research Center, Sirius University of Science and Technology, 354340 Sochi, Russia.
Ivan KukushkinTranslational Medicine Research Center, Sirius University of Science and Technology, 354340 Sochi, Russia.ORCID 0000-0003-4594-9941
Alisa KazakovaTranslational Medicine Research Center, Sirius University of Science and Technology, 354340 Sochi, Russia.
Dmitry KunykTranslational Medicine Research Center, Sirius University of Science and Technology, 354340 Sochi, Russia.
Anna KirshinaTranslational Medicine Research Center, Sirius University of Science and Technology, 354340 Sochi, Russia.ORCID 0009-0002-6379-084X
Olga VasilevaTranslational Medicine Research Center, Sirius University of Science and Technology, 354340 Sochi, Russia.
Kristina SereginaTranslational Medicine Research Center, Sirius University of Science and Technology, 354340 Sochi, Russia.
Ildus PateevTranslational Medicine Research Center, Sirius University of Science and Technology, 354340 Sochi, Russia.
Fedor KolpakovTranslational Medicine Research Center, Sirius University of Science and Technology, 354340 Sochi, Russia.
Roman IvanovTranslational Medicine Research Center, Sirius University of Science and Technology, 354340 Sochi, Russia.ORCID 0000-0002-9573-4183
Sirius University of Science and Technology · RUCentral Scientific Research Institute of Tuberculosis Russian Academy of Medical Sciences · RULomonosov Moscow State University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

mRNA vaccines have been shown to be effective in combating the COVID-19 pandemic. The amount of research on the use of mRNAs as preventive and therapeutic modalities has undergone explosive growth in the last few years. Nonetheless, the issue of the stability of mRNA molecules and their translation efficiency remains incompletely resolved. These characteristics of mRNA directly affect the expression level of a desired protein. Regulatory elements of RNA-5' and 3' untranslated regions (UTRs)-are responsible for translation efficiency. An optimal combination of the regulatory sequences allows mRNA to significantly increase the target protein's expression. We assessed the translation efficiency of mRNA encoding of firefly luciferase with various 5' and 3'UTRs in vitro on cell lines DC2.4 and THP1. We found that mRNAs containing 5'UTR sequences from eukaryotic genes

Indexed as

Blood Group AntigensTuberculosis3' Untranslated Regions5' Untranslated RegionsAnimalsBNT162 VaccineHumansMiceMice, Inbred C57BLmRNA VaccinesPandemicsRNA, Messenger3' Untranslated Regions5' Untranslated RegionsBlood Group AntigensBNT162 VaccinemRNA VaccinesRNA, Messenger3′UTR5′UTRmRNA therapeuticstranslation efficiency

Identifiers

PMID38255961
PMCPMC10815675
OpenAlexW4390806630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.